Delta Plus Group reported revenue of €94.6 million in the first quarter of 2025, down 1.3% year-on-year. This decline amounts to 2.4% at constant scope and exchange rates. The company, which ...

Fleury Michon has published its share buyback statement for the period from May 12 to 16, 2025. The company repurchased a total of 197 shares of its own capital during this period. The transactions ...

Mercialys, a French public limited company with a capital of 93,886,501 euros, has disclosed its current share and voting rights data as of April 30, 2025. According to Article 223-16 of the General ...

Forsee Power, a leader in battery systems for commercial and industrial electric vehicles, has updated its 2025 financial targets. The company reported a promising revenue increase in the first ...

Aramis Group announced robust financial results for the first half of 2025, ending March 31. Revenues reached €1,213.3 million, marking a 10% organic increase from the same period in 2024. The number ...

For the first quarter of 2025, Groupe Beneteau reported revenues of €130 million, a decrease of 43% compared to the same period last year. The decline is attributed to reduced demand across boat ...

Leclanché SA, a major player in energy storage, announced that it has requested an extension to publish its 2024 annual report. The company missed the deadline initially set by SIX Exchange Regulation ...

Bureau Veritas has issued a press release regarding the share buyback carried out between May 8 and 9, 2025. During this period, the company acquired a total of 819,703 shares. These transactions were ...

VusionGroup has announced the resignation of Ms. Rong Huang, a director affiliated with BOE, amid a reduction in BOE's shareholding from 32% to 25%. The company aims to fortify its governance by ...

On May 13, 2025, Renault Group, through its Mobilize brand, and Autostrade per l'Italia (ASPI), through Free To X, finalized a strategic alliance. This collaboration aims to develop the fast-charging ...

Semperit AG Holding experienced a challenging first quarter in 2025, impacted by persistent market difficulties and uncertainties related to US tariffs. The company reported a 13.8% year-over-year ...

Onco-Innovations Limited has announced that Dalton Pharma Services has begun manufacturing material for preclinical testing of their PNKP inhibitor technology. This marks a move from early research to ...